| Summary: | Recurrent myocardial infarction (re-MI) is a common event following acute
coronary syndrome (ACS), especially during the first year. According to
epidemiological studies, patients who experience re-MI are at higher risk of
all-cause cardiovascular events and mortality. The cornerstones of re-MI
prevention include complete functional coronary revascularization, effective dual
antiplatelet therapy and secondary prevention strategies. Notwithstanding this,
some controversy still exists on the definition and management of re-MI, and no
dedicated studies have been designed or conducted so far in this setting. We here
provide an overview of epidemiological and prognostic data on ACS patients
experiencing re-MI, along with current available treatment and preventive
options.
|
|---|